Messenger RNA was identified experimentally in 1961, primarily through two parallel sets of experiments: one led by Sydney Brenner, François Jacob, and Matthew Meselson at Caltech, and another by François Gros and colleagues working between Harvard and the Pasteur Institute in Paris. The concept itself, though, emerged from theoretical work by Jacob and Jacques Monod slightly earlier, and the trail of clues stretches back to the mid-1950s. Pinning the discovery on a single person or a single moment misses how the idea of a short-lived messenger molecule crystallized across multiple labs and multiple years.
The Problem That Needed Solving
By the mid-1950s, molecular biologists had a puzzle. DNA clearly stored genetic information, and proteins clearly did the cell’s work, but nobody understood the middleman. How did the instructions in DNA get turned into proteins? The ribosomes, those tiny cellular factories where proteins are assembled, were known to contain a lot of RNA. For a while, most researchers assumed the ribosomal RNA itself carried the genetic instructions. Each ribosome, the thinking went, was essentially pre-loaded with the plan for one particular protein.
A hint that something else was going on came in 1956, when Elliot Volkin and Lazarus Astrachan at Oak Ridge National Laboratory noticed something odd in bacteria infected with a virus. A new kind of RNA appeared rapidly after infection, and its chemical composition mirrored the viral DNA rather than the bacteria’s own genes.1Virology. Intracellular distribution of labeled ribonucleic acid after phage infection of Escherichia coli This “DNA-like RNA” was unstable, disappearing almost as fast as it appeared. At the time, nobody quite knew what to make of it. The observation sat in the literature like an unexplained anomaly for several years.
Meanwhile, in September 1957, Francis Crick delivered a lecture at University College London in which he laid out what he called the Central Dogma: information flows from DNA to RNA to protein, and not in reverse from protein back to nucleic acid.2PubMed Central. 60 years ago, Francis Crick changed the logic of biology Alongside this, Crick proposed the Sequence Hypothesis, the idea that the order of building blocks in a nucleic acid chain dictates the order of amino acids in a protein.3PubMed. The Central Dogma revisited: Insights from protein synthesis, CRISPR, and beyond Crick’s framework gave the field a logical skeleton: some form of RNA must be carrying the message from DNA to ribosomes. But nobody had caught that molecule in the act.
Jacob and Monod Imagine the Messenger
The key theoretical leap came from François Jacob and Jacques Monod at the Pasteur Institute in Paris. Working on how bacteria switch genes on and off, they realized the existing model was wrong. Ribosomes could not each be hardwired to produce one protein, because bacteria can start making entirely new proteins within minutes of being exposed to a new food source or a viral infection. The ribosomes had to be general-purpose machines, and something else had to deliver the specific instructions.
By 1960, Jacob and Monod proposed the existence of a short-lived RNA intermediary. It would be copied from DNA, carry the blueprint to ribosomes, direct protein assembly, and then be broken down. Jacob later recalled a pivotal conversation at Brenner’s flat in Cambridge in the spring of 1960, where he and Brenner suddenly connected the dots: Volkin and Astrachan’s mysterious unstable RNA from 1956 was exactly the kind of molecule that their model predicted. The realization was electrifying, and they immediately began planning experiments to prove it.
The Summer of 1961
The experimental proof arrived in two landmark papers published in Nature in May 1961. Brenner, Jacob, and Meselson used an elegant technique. They grew bacteria on heavy isotopes so the existing ribosomes would be “heavy,” then infected the cells with a virus and switched to light growth medium. Any new RNA that turned up on the old, heavy ribosomes had to be a fresh message from the viral DNA, not a new ribosome. That is exactly what they found: a rapidly made, short-lived RNA that associated with pre-existing ribosomes and directed the synthesis of viral proteins.4Nature. An Unstable Intermediate Carrying Information from Genes to Ribosomes for Protein Synthesis Their paper stated plainly that this messenger RNA “does not serve as a permanent template” and that ribosomes are “non-specific structures which can interact with any given species of messenger RNA.”
The parallel paper, by François Gros and collaborators including James Watson, reached essentially the same conclusion using a different experimental approach in uninfected bacteria. Together, the two studies demolished the old one-ribosome-one-protein model and established that a transient RNA messenger carried genetic instructions to general-purpose ribosomes. The announcement of mRNA’s discovery and early steps toward cracking the genetic code happened within weeks of each other that summer, creating a burst of progress that reshaped biology.5Current Biology. Who discovered messenger RNA?
Who Gets the Credit?
Assigning credit for the discovery of mRNA is genuinely complicated. Jacob and Monod deserve recognition for the theoretical prediction that made the experiments possible. Brenner, Jacob, and Meselson produced one of the decisive experimental demonstrations. Gros and his colleagues produced the other. Volkin and Astrachan had the first physical evidence of the molecule five years earlier, even though they did not identify what it was. And Crick’s Central Dogma provided the intellectual scaffolding that made a messenger molecule seem necessary in the first place.
If you had to name a single person most often associated with mRNA’s discovery, it would probably be François Jacob, who appears on both the theoretical and experimental sides: he co-developed the messenger hypothesis with Monod and co-authored the Brenner-Jacob-Meselson experiment. But the discovery was genuinely collaborative in a way that resists any single-hero narrative. Jacob and Monod shared the 1965 Nobel Prize in Physiology or Medicine with André Lwoff, primarily for their work on gene regulation rather than for mRNA specifically, which gives some sense of how intertwined the messenger concept was with a broader revolution in understanding gene expression.
Verification and the Genetic Code
After the 1961 papers, the field moved fast to verify and extend the discovery. One critical technique was DNA-RNA hybridization, developed by Sol Spiegelman and others in the early 1960s. The method allowed researchers to test whether an RNA molecule was truly copied from a specific stretch of DNA by seeing whether the two would bind together based on matching sequences. This bridged the gap between the theoretical idea of information transfer and direct physical evidence that specific RNA molecules were copied from specific genes.6PubMed. Not just “a clever way to detect whether DNA really made RNA”: The invention of DNA-RNA hybridization and its outcome
Also in 1961, Marshall Nirenberg and Heinrich Matthaei at the National Institutes of Health made a related breakthrough. They showed that a synthetic RNA made entirely of one nucleotide could direct the production of a simple protein in a cell-free system.7Proceedings of the National Academy of Sciences. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides This was the first step in cracking the genetic code, the dictionary that translates RNA sequences into amino acid sequences. Their work provided powerful indirect confirmation that RNA was indeed the informational intermediate between DNA and protein.
mRNA Turns Out to Be More Elaborate Than Expected
The mRNA found in bacteria was simple: a naked strand of RNA, quickly made and quickly destroyed. But as researchers turned their attention to more complex organisms in the late 1960s and 1970s, they discovered that eukaryotic mRNA is far more elaborately constructed. Three discoveries in particular revealed how different the molecule looks in animal and plant cells.
First, in 1971, researchers found that messenger RNA in eukaryotic cells carries a long tail of repeated adenine nucleotides, called a poly(A) tail, typically 150 to 250 nucleotides long.8PubMed. Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA This tail turned out to protect the mRNA from being chewed up too quickly and to help with its export from the cell’s nucleus.
Second, in the mid-1970s, the 5′ cap was discovered: a chemically modified guanosine nucleotide stuck onto the front end of the mRNA. Studies showed that this cap structure, specifically a 7-methylguanosine, is required for the mRNA to be efficiently translated into protein.9PubMed. 5′-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation Without proper methylation of the cap, ribosomes largely ignore the message.10PubMed. Ribosome binding to reovirus mRNA in protein synthesis requires 5′ terminal 7-methylguanosine
Third, and perhaps most surprising, was the discovery in 1977 that eukaryotic genes are interrupted by non-coding stretches of DNA called introns. The initial RNA copy of a gene includes these introns, but they get snipped out before the mature mRNA leaves the nucleus. None of this complexity exists in bacteria, where mRNA is used almost immediately after being transcribed. These findings revealed that the journey from gene to protein is far more regulated in complex organisms, with multiple opportunities for the cell to control which proteins get made, how much, and when.
The discovery of three distinct RNA polymerase enzymes in eukaryotes in 1969, each responsible for transcribing a different class of RNA, was another milestone. RNA polymerase II was identified as the enzyme specifically dedicated to making mRNA, and its study opened decades of research into how cells regulate transcription.11PubMed Central. 50+ years of eukaryotic transcription: an expanding universe of factors and mechanisms
Why mRNA Was So Hard to Find
One reason mRNA eluded researchers for so long is that it is inherently unstable. That instability is not a flaw; it is a feature. mRNA is supposed to be temporary. A cell needs to respond quickly to changing conditions, and long-lived mRNA would make that impossible. In bacteria, most mRNA molecules survive only a few minutes before being broken down. In eukaryotic cells, lifetimes range from minutes to hours, and in rare cases days, but the default is still rapid turnover.
Despite the structural differences between bacterial and eukaryotic mRNA, the basic logic of degradation turns out to be surprisingly similar across all life. Both systems use enzymes that chew RNA from its ends, and both use internal cleavage to accelerate the process when needed.12PubMed Central. All things must pass: contrasts and commonalities in eukaryotic and bacterial mRNA decay Early researchers assumed the mechanisms were completely different, but subsequent work revealed parallel strategies. The transient nature of mRNA made it nearly invisible with the technology available in the 1950s, which is part of why Volkin and Astrachan’s 1956 observation took years to be properly interpreted.
From Laboratory Curiosity to Medicine
For decades after its discovery, mRNA was mainly a subject of basic research. The idea of using synthetic mRNA as a drug or vaccine ingredient seemed far-fetched, because the molecule is fragile and the immune system tends to attack foreign RNA aggressively. The path from lab bench to clinic required solving both problems.
An early proof of concept came in 1989, when Robert Malone and colleagues demonstrated that synthetic mRNA could be delivered into living cells using lipid-based carriers called liposomes. The method worked across human, mouse, rat, frog, and fly cells, establishing that mRNA transfection was technically feasible.13PubMed Central. Cationic liposome-mediated RNA transfection But getting cells to accept mRNA and actually produce a useful amount of protein from it, without triggering a violent immune reaction, remained a major barrier.
The breakthrough that eventually made mRNA vaccines possible came from Katalin Karikó and Drew Weissman at the University of Pennsylvania. In 2005, they showed that naturally occurring chemical modifications to RNA nucleosides, such as pseudouridine, could prevent the immune system’s toll-like receptors from recognizing and attacking the RNA. Immune cells exposed to modified RNA produced far fewer inflammatory signals than those exposed to unmodified RNA.14PubMed. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA A follow-up study confirmed that incorporating pseudouridine into mRNA also increased how much protein the cells produced and improved the mRNA’s stability, all while eliminating the immune activation that had plagued earlier attempts.15PubMed Central. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability Karikó and Weissman received the 2023 Nobel Prize in Physiology or Medicine for this work.
The other essential piece was delivery. Naked mRNA injected into the body gets destroyed almost immediately by enzymes in the blood and tissues. Lipid nanoparticles solved this by wrapping the mRNA in a tiny fat bubble that protects it from degradation, helps it enter cells, and can be manufactured at scale.16PubMed Central. mRNA vaccine delivery using lipid nanoparticles The combination of nucleoside-modified mRNA and lipid nanoparticle delivery is the technology that powered the Pfizer-BioNTech and Moderna COVID-19 vaccines, which marked the first time mRNA therapeutics reached widespread clinical use.17Nature Reviews Materials. Lipid nanoparticles for mRNA delivery
mRNA Before DNA
The discovery of mRNA reshaped how biologists think about the present-day cell, but it has also influenced thinking about life’s origins. In modern cells, the flow of information runs from DNA to RNA to protein, as Crick outlined. But there is a longstanding hypothesis that RNA came first. The RNA world hypothesis proposes that early life relied on RNA molecules that could both store genetic information and catalyze chemical reactions, roles now divided between DNA and protein.18PubMed Central. The RNA world hypothesis: the worst theory of the early evolution of life (except for all the others)
The evidence for this idea is indirect but substantial. RNA is the catalytic core of the ribosome, the machine that builds proteins. RNA viruses use RNA as their genome. And laboratory experiments have shown that RNA molecules can evolve the ability to catalyze a range of chemical reactions. The ubiquity of RNA in cellular processes, from gene regulation to protein synthesis, is difficult to explain unless RNA played a central role much earlier in evolutionary history.19Metode Science Studies Journal. The RNA World: Piecing together the historical development of a hypothesis In this view, the messenger RNA of today is a relic of a time when RNA was not just the messenger but the entire operating system. Whether or not the RNA world hypothesis holds up in every detail, it reframes the mRNA molecule as something far older and more fundamental than the supporting player it might seem in a modern textbook diagram.